KEEVA THURMOND: Open Payments
NPI 1417514993 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$924 in 44 payments from 11 companies in 2025. Trend: 2023 $1,900 · 2024 $1,556 · 2025 $924
Food & beverage: $924
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $237 |
| Lilly USA, LLC | 6 | $126 |
| PFIZER INC. | 6 | $118 |
| Novo Nordisk Inc | 6 | $110 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $91 |
| ABBVIE INC. | 4 | $78 |
| Amgen Inc. | 3 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Dexcom, Inc. | 1 | $21 |
Products named: AIRSUPRA, NURTEC ODT, MOUNJARO, FARXIGA, Kerendia, Wegovy, QULIPTA, JARDIANCE.
Industry payments across MA — which companies pay providers there.
